148 related articles for article (PubMed ID: 36635514)
1. Assessment of diffusion-weighted MRI in predicting response to neoadjuvant chemotherapy in breast cancer patients.
Hottat NA; Badr DA; Lecomte S; Besse-Hammer T; Jani JC; Cannie MM
Sci Rep; 2023 Jan; 13(1):614. PubMed ID: 36635514
[TBL] [Abstract][Full Text] [Related]
2. Value of diffusion-weighted MRI in predicting early response to neoadjuvant chemotherapy of breast cancer: comparison between ROI-ADC and whole-lesion-ADC measurements.
Hottat NA; Badr DA; Lecomte S; Besse-Hammer T; Jani JC; Cannie MM
Eur Radiol; 2022 Jun; 32(6):4067-4078. PubMed ID: 35015127
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer.
Richard R; Thomassin I; Chapellier M; Scemama A; de Cremoux P; Varna M; Giacchetti S; Espié M; de Kerviler E; de Bazelaire C
Eur Radiol; 2013 Sep; 23(9):2420-31. PubMed ID: 23652844
[TBL] [Abstract][Full Text] [Related]
4. Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
Nilsen L; Fangberget A; Geier O; Olsen DR; Seierstad T
Acta Oncol; 2010 Apr; 49(3):354-60. PubMed ID: 20397769
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy induces an elevation of tumour apparent diffusion coefficient values in patients with ovarian cancer.
Reijonen M; Holopainen E; Arponen O; Könönen M; Vanninen R; Anttila M; Sallinen H; Rinta-Kiikka I; Lindgren A
BMC Cancer; 2023 Apr; 23(1):299. PubMed ID: 37005578
[TBL] [Abstract][Full Text] [Related]
6. Diffusion-weighted MRI for predicting pathologic response to neoadjuvant chemotherapy in breast cancer: evaluation with mono-, bi-, and stretched-exponential models.
Suo S; Yin Y; Geng X; Zhang D; Hua J; Cheng F; Chen J; Zhuang Z; Cao M; Xu J
J Transl Med; 2021 Jun; 19(1):236. PubMed ID: 34078388
[TBL] [Abstract][Full Text] [Related]
7. Investigating the prediction value of multiparametric magnetic resonance imaging at 3 T in response to neoadjuvant chemotherapy in breast cancer.
Minarikova L; Bogner W; Pinker K; Valkovič L; Zaric O; Bago-Horvath Z; Bartsch R; Helbich TH; Trattnig S; Gruber S
Eur Radiol; 2017 May; 27(5):1901-1911. PubMed ID: 27651141
[TBL] [Abstract][Full Text] [Related]
8. Early prediction of response to neoadjuvant chemotherapy in patients with breast cancer using diffusion-weighted imaging and gray-scale ultrasonography.
Iwasa H; Kubota K; Hamada N; Nogami M; Nishioka A
Oncol Rep; 2014 Apr; 31(4):1555-60. PubMed ID: 24535214
[TBL] [Abstract][Full Text] [Related]
9. The role of ADC value and Ki-67 index in predicting the response to neoadjuvant chemotherapy in advanced stages of olfactory neuroblastoma.
Wang Y; Zhang S; Yu W; Wang Y; Yan F; Yang B
Br J Radiol; 2022 Dec; 95(1140):20220367. PubMed ID: 36240450
[TBL] [Abstract][Full Text] [Related]
10. Changes in Apparent Diffusion Coefficient as Surrogate Marker for Changes in Ki-67 Index Due to Neoadjuvant Chemotherapy in Patients with Invasive Breast Cancer.
Luo N; Ji Y; Huang X; Liu Y; Liu L; Jin G; Zhao X; Zhu X; Su D
Acad Radiol; 2019 Oct; 26(10):1352-1357. PubMed ID: 30711409
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy.
Sharma U; Danishad KK; Seenu V; Jagannathan NR
NMR Biomed; 2009 Jan; 22(1):104-13. PubMed ID: 18384182
[TBL] [Abstract][Full Text] [Related]
12. Role of the Apparent Diffusion Coefficient in the Prediction of Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer.
Bufi E; Belli P; Costantini M; Cipriani A; Di Matteo M; Bonatesta A; Franceschini G; Terribile D; Mulé A; Nardone L; Bonomo L
Clin Breast Cancer; 2015 Oct; 15(5):370-80. PubMed ID: 25891905
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous changes of magnetic resonance diffusion-weighted imaging and pathological microstructure in locally advanced cervical cancer caused by neoadjuvant chemotherapy.
Fu C; Feng X; Bian D; Zhao Y; Fang X; Du W; Wang L; Wang X
J Magn Reson Imaging; 2015 Aug; 42(2):427-35. PubMed ID: 25328994
[TBL] [Abstract][Full Text] [Related]
14. Can whole-tumor apparent diffusion coefficient histogram analysis be helpful to evaluate breast phyllode tumor grades?
Guo Y; Tang WJ; Kong QC; Liang YY; Han XR; Zheng BJ; Sun L; Wei XH; Jin Z; Liu CL
Eur J Radiol; 2019 May; 114():25-31. PubMed ID: 31005172
[TBL] [Abstract][Full Text] [Related]
15. Assessing the Early Response of Advanced Cervical Cancer to Neoadjuvant Chemotherapy Using Intravoxel Incoherent Motion Diffusion-weighted Magnetic Resonance Imaging: A Pilot Study.
Wang YC; Hu DY; Hu XM; Shen YQ; Meng XY; Tang H; Li Z
Chin Med J (Engl); 2016 Mar; 129(6):665-71. PubMed ID: 26960369
[TBL] [Abstract][Full Text] [Related]
16. Additive value of diffusion-weighted MRI in the I-SPY 2 TRIAL.
Li W; Newitt DC; Wilmes LJ; Jones EF; Arasu V; Gibbs J; La Yun B; Li E; Partridge SC; Kornak J; ; Esserman LJ; Hylton NM
J Magn Reson Imaging; 2019 Dec; 50(6):1742-1753. PubMed ID: 31026118
[TBL] [Abstract][Full Text] [Related]
17. Impact of Machine Learning With Multiparametric Magnetic Resonance Imaging of the Breast for Early Prediction of Response to Neoadjuvant Chemotherapy and Survival Outcomes in Breast Cancer Patients.
Tahmassebi A; Wengert GJ; Helbich TH; Bago-Horvath Z; Alaei S; Bartsch R; Dubsky P; Baltzer P; Clauser P; Kapetas P; Morris EA; Meyer-Baese A; Pinker K
Invest Radiol; 2019 Feb; 54(2):110-117. PubMed ID: 30358693
[TBL] [Abstract][Full Text] [Related]
18. Diffusion-weighted imaging in evaluating the response to neoadjuvant breast cancer treatment.
Belli P; Costantini M; Ierardi C; Bufi E; Amato D; Mule' A; Nardone L; Terribile D; Bonomo L
Breast J; 2011; 17(6):610-9. PubMed ID: 21929557
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of pretreatment ADC values as predictors of treatment response to neoadjuvant chemotherapy in patients with breast cancer - a multicenter study.
Surov A; Pech M; Meyer HJ; Bitencourt AGV; Fujimoto H; Baxter GC; Santamaría G; Gilbert FJ; Wienke A
Cancer Imaging; 2022 Dec; 22(1):68. PubMed ID: 36494872
[TBL] [Abstract][Full Text] [Related]
20. Correlation of Apparent Diffusion Coefficient With Proliferation and Apoptotic Indexes in a Murine Model of Fibrosarcoma: Comparison of Four Methods for MRI Region of Interest Positioning.
Yang Y; Fang S; Tao J; Liu Y; Wang C; Yin Z; Chen B; Duan Z; Liu W; Wang S
J Magn Reson Imaging; 2023 May; 57(5):1406-1413. PubMed ID: 35864603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
